Lorcaserin

FDA advisers recommend approving weight loss drug
Advisers to government health regulators have recommended that that they approve sales of what would be the first new prescription weight-loss drug in the US in more than a decade, despite concerns over cardiac risks. Thu, 05/10/2012 - 8:57pm